LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$20.27
-0.38 (-1.84%)
âŧ
5d:
+5.13%
30d:
-12.02%
90d:
-29.3%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LEGN is fairly priced but lacks strong directional signals. At -19.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LEGN is fairly priced but lacks strong directional signals. At -19.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$53.76
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$33.38
39.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $20.27, which is considered slightly low relative to its 30-day fair value range of $19.27 to $25.48. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.4) compared to its historical average (34.6). Remarkably, the market is currently pricing in an annual earnings decline of 19.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is showing sideways momentum. Immediate support is located at $18.33, while resistance sits at $22.35.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.10 (+157.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEGN is showing sideways momentum. Immediate support is located at $18.33, while resistance sits at $22.35.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.10 (+157.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$19.27 -
$25.48
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 157.0% below Wall St target ($52.10)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.27 -
$25.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$18.33
Resistance Level
$22.35
Current Trend
Sideways
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.36
Wall Street Target
$52.10
(+157.0%)
Revenue Growth (YoY)
51.9%
Profit Margin
-7.2%
Valuation Discount vs History
-19.0% cheaper
PE vs Historical
18.4 vs 34.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.0%
(market-implied from PE analysis)
1-Year Target
$18.24
(-10%)
2-Year Target
$16.42
(-19%)
3-Year Target
$14.78
(-27%)
3-Yr Target (if PE normalizes)
(PE: 18â35)
$27.85
(+37%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 294.4%)
$75.39
(+272%)
Base:
(SPY PE: 18.4, Growth: 294.4%)
$68.41
(+238%)
Bear:
(PE: 15.6, Growth: 294.4%)
$58.15
(+187%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.4 to 34.6
Stabilization Target:
$38.21
(+88.5%)
PE Expansion Potential:
+88.5%
Share & Embed Analysis
Last updated: August 13, 2026 5:50 PM ET
Data refreshes hourly during market hours. Next update: 6:50 PM
Data refreshes hourly during market hours. Next update: 6:50 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$376 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$431 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 52 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$559 | 27 SELL |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
